Growth Metrics

RxSight (RXST) Long-Term Deferred Tax (2022 - 2023)

RxSight (RXST) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $1.2 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Long-Term Deferred Tax changed N/A year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Dec 2022, changed N/A, and an annual FY2022 reading of $1.2 million, changed N/A over the prior year.
  • Long-Term Deferred Tax was $1.2 million for Q4 2022 at RxSight.
  • Across five years, Long-Term Deferred Tax topped out at $1.2 million in Q4 2022 and bottomed at $1.2 million in Q4 2022.